J&J - Bio E aims to manufacture 400mn doses of Covid vaccine in a year: Paul Stoffels

J&J - Bio E aims to manufacture 400mn doses of Covid vaccine in a year: Paul StoffelsПодробнее

J&J Expects to Deliver Covid Shots in March, CSO Stoffels SaysПодробнее

Johnson & Johnson's Paul Stoffels MD, Vaccine Development | Global Goal: Unite for Our FutureПодробнее

Paul Stoffels COVID-19 Update | Johnson & JohnsonПодробнее

US ready to distribute up to 4 million doses of J&J vaccine next week if approved, WH says | FULLПодробнее

COVID-19: Johnson & Johnson on vaccine production capacityПодробнее

India to manufacture Johnson & Johnson’s Covid-19 vaccine as part of Quad initiativeПодробнее

J&J Vaccine Manufacturing Error Affects 15 Million DosesПодробнее

J&J Is Preparing to Manufacture Massive Amounts of Covid-19 VaccineПодробнее

J&J Starts Testing Single-Dose Covid VaccineПодробнее

Paul Stoffels BBC InterviewПодробнее

What Our “New Normal” Might Look Like Until We Get a COVID-19 VaccineПодробнее

J&J expects vaccine approval in US 'within a month'Подробнее

U.S. to Deliver 3.9 Million Johnson & Johnson Vaccine DosesПодробнее

A Quick Lesson in Thorough Handwashing from Dr. Paul StoffelsПодробнее

Paul Stoffels (J&J) - GapSummit 2018 InterviewsПодробнее

How J&J Is Stepping Up to Help During the Current PandemicПодробнее

The U.S. will have 400 million Covid-19 vaccine doses by JulyПодробнее

J&J chief scientist on phase 3 trial for coronavirus vaccineПодробнее

WHO Aims to Make 2 Billion Doses of Vaccine Available by End of 2021Подробнее